Shri J P Nadda chairs high level review meeting on prevention and control of vector borne diseases in Delhi

New Delhi, August 22, 2017: Stresses on importance of community participation, awareness drives, adequate preparedness of hospitals, and cooperation of all stakeholders Shri J P Nadda, Union Minister for Health and Family Welfare held a high level meeting to review the activities for prevention and control of vector borne diseases (dengue, malaria, chikungunya and swine flu) in Delhi, here today. Shri Satyendra Jain, Health Minister, Government of Delhi, Mayors of Delhi, Shri C K Mishra, Union Health Secretary, Dr Soumya Swaminathan, Secretary (DHR), Dr Jagdish Prasad, DGHS, Medical Supdts.

New pharma policy may fix drug trade margins

New Delhi, August 22, 2017: In an attempt to make drugs affordable to all, the government has planned a fresh pharmaceutical policy. The policy draft says that the government will fix trade margins for drugs as well. At present, the National Pharmaceutical Pricing Authority (NPPA) is in the process of fixing trade margins for a number of medical devices like orthopedic knee implants and cardiac stents according to Business-standard.com. According to the draft, which Business Standard reviewed, “The issue of unreasonable trade margins and bonus offers by various stockists, distributors and re

Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria

· Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission · KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies · Clinical trial has started early August in adults with malaria and is planned to expand to adolescents and children in a total of nine countries in Africa and Asia Basel, August 22, 2017: Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generat

ZenQ Freedom Cycle Ride 2017, a 30kms cycle ride by 125 IT employees held

Hyderabad based software testing services company, ZenQ to introduce height adjustable Workstations(stand & work stations) in its newly coming up 1.09 lakh sqft facility, to ensure its software engineers stay fit with office job Murali Bollu, MD of ZenQ, India, and US headquartered fast growing pure-play testing services company welcomes the HMD’s proposed Cycling Track along the ORR, which would develop more cycling culture in the city The young software engineers who are getting into the profession must ‘fit, fitness into their work”: Murali Bollu Hyderabad, August 22, 2017: ..3

Vitafoods Asia 2017 Heralds a New Future of Innovation

Inspiring Industry with Next-generation Nutraceuticals & Incisive Learning Opportunities Singapore, August 22, 2017: The seventh edition of Vitafoods Asia, the only event dedicated to the nutraceutical, functional food and beverages, and dietary supplement industries in Asia, will take place from 5 – 6 September at the Sands Expo and Convention Centre in Marina Bay Sands, Singapore. Centred around doing business, learning, and networking, the event expects to welcome over 3,000 trade professionals through its doors, to discover the latest innovations presented by over 250 suppliers and

Abbott Increases Access of Widest Nutrition Portfolio for Rare Metabolic Disorders in India

Collaboration With Healthcare Providers, Nutritionists And Government Allows For Immediate Availibility, Ensuring Faster Access To Babies In Need Of Critical Nutrition Mumbai, August 22, 2017: Abbott, a leader in nutrition science research and development, has announced increased access to Abbott’s nutrition metabolic formulas (ANMF)to help infants diagnosed with Inborn Errors of Metabolism (IEM) in India. The announcement comes on the back of easing of import regulations by the country’s regulatory authority – FSSAI (Food Safety and Standards Authority of India) under the Diet4Life in

Columbia Asia Hospitals CEO awarded “Healthcare Personality of The Year” by FICCI

Bangalore, August 22, 2017: Indian healthcare is growing at a tremendous pace today, owing to its strengthening expansion and services by both public and private players in the sector. Several healthcare organizations and individuals, through their dedication and determination for innovative solutions have contributed positively in countering the challenges that lurk large, on the healthcare sector. The Healthcare Excellence Awards by the Federation of Indian Chambers of Commerce and Industry(FICCI), is an attempt in recognizing the contributions of those who have set benchmarks of excellenc

Pitney Bowes Concludes Code Inspire 2.0: An Exclusive Hackathon For Women

With over 2500 women participating in Code Inspire 2.0, Pitney Bowes continues to encourage 'Women in Tech' New Delhi, August 22, 2017: Aimed at enhancing women representation in technology, Pitney Bowes Inc. (NYSE: PBI), a global technology company that provides innovative products and solutions to power commerce, today announced the winners of its second diversity hackathon 'Pitney Bowes Code Inspire 2.0', targeted at women in colleges, working professionals and those who have taken a career break. Pitney Bowes Code Inspire 2.0 was a week-long programming marathon which had over 2500+ pa

Godrej Security Solutions urges women to take charge of their security

Kick Starts multi-city campaign #IAm Secure; over 150 women in Mumbai take the 'Pledge of Security' Mumbai, August 22, 2017: Godrej Security Solutions, India's leading security solutions provider, kick started a multi-city consumer awareness programme and campaign #IAM SECURE [1]. The objective of this campaign, the first leg of which was held today in Mumbai at Godrej One, is to create awareness among women to be more proactive and take charge of their own security, educate them about the various solutions and also educate them about the importance of learning self-defense for leadin

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

Memorandum of Understanding brings together best scientists from India and Johnson & Johnson to increase level and accelerate pace of innovation needed to make TB history Bengaluru, August 20, 2017: Johnson & Johnson Private Limited today announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to unlock the potential of Indian science and help accelerate the discovery of innovative new treatments for tuberculosis (TB). Under the Memorandum of Understanding, scientists from Johnson & Johnson

Lung transplant- A ray of hope Dr Syed Z Tousheed, Dr Basha J Khan, Dr BV Murali Mohan - Lung Transplant Physicians- Narayana Health City , Bangalore

New Delhi, August 20, 2017: Respiratory diseases are one of the largest killers across the globe. They rank second, next only to accidents in conditions causing death in the Indian population. Respiratory diseases do not only cause suffering, they also impose a huge economic burden on the nation. The picture is more devastating if the younger population or the earning members of the family are affected with these disorders. Thousands of people of all ages are victims of these terrible conditions such as chronic obstructive pulmonary disease (COPD), fibrotic lung diseases, bronchiectasis (a typ

Columbia Clinic launched at Embassy TechVillagein Bangalore

Will cater to more than 20,000 professionals from companies including Wells Fargo, Cisco, Sony, LG and Flipkart Bangalore, August 20, 2017: Over the last two decades there has been an alarmingrise in cardiovascular disease, diabetes, hypertension, asthma and respiratory diseases and cancers in India, especially among the urban population. According to statistics, every year, roughly 5.8 million Indians die from heart and lung diseases, stroke, cancer and diabetes. Around 50.8 million population are affected by diabetes alone, as per WHO records. Another 15 per cent suffers from arthritis, as

The Great Hall of China: double digit growth at CPhI China

The Asian giant Pharma event surpasses 55,000 visits with more than 10,000 overseas visits Amsterdam, August 19, 2017: CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), closed in June 2017 with a very successful show, reporting a positive outlook for the Chinese pharmaceutical market's development. Since 2016, CPhI China has experienced a 14% growth in overall visits and a 12% growth in overseas visits – a remarkable achievement for a mature market with 17 previous editions behind it

Philips Avent promotes breastfeeding awareness campaign conceptualised by Pulp Strategy

The awareness campaign is aimed at empowering mothers, mothers-to-be, and their families New Delhi, August 19, 2017: Royal Philips, a global leader in healthcare technology, has recently rolled out an awareness campaign aimed to empower mothers, expecting mothers, and their families in India. Launched under the Philips Avent brand, the campaign promotes the importance of breastfeeding, address societal barriers, while also introducing solutions to prolong breastfeeding as much as possible. As a part of the campaign, Philips Avent supports breast feeding for babies as long as possible, has ro

ESA Medical Resources is Now Recruiting Bariatric Surgeons in Arizona

ESA Medical Resources is now recruiting bariatric surgeons near Tucson, Arizona. Tucson, August 19, 2017: This is a great opportunity to join a highly successful private bariatric surgery practice in sunny Arizona. The practice is seeking a fellowship trained bariatric surgeon to join their growing practice. They are accepting experienced bariatric surgeons and newly trained fellowship candidates. The practice is offering a very competitive compensation package. The program is a COE and in existence for nine years, performing all types of bariatric procedures. The practice serves a population

Upcoming Events
National 'Arogya Fair' 2017

National 'Arogya Fair' 2017... PHD Chamber of Commerce and In

Vascular Biology 2017

Vascular Biology 2017... The committee of International

Clinical Trials 2017

Clinical Trials 2017... 4th International Conference o

Metabolomics Conference 2017

Metabolomics Conference 2017... “9th International Conferen

Nucleic Acids 2017

Nucleic Acids 2017... We are pleased to invite the c

Biosimilars Asia 2017

Biosimilars Asia 2017... 8th Asian Biosimilars Congre

Pharmacognosy 2017

Pharmacognosy 2017... Conference Series LLC invites

Heart Diseases 2017

Heart Diseases 2017... The Annual Conference on Heart

19th Euro Cancer Science and Therapy Congress

19th Euro Cancer Science and Therapy Congress... Conference Series LLC extends

Structural Biology 2017

Structural Biology 2017... Conference Series LLC welcome

Clinical Research 2017

Clinical Research 2017... Clinical Research 2017 Confere

Pharmaceutical and Biomedical Engineering 2017

Pharmaceutical and Biomedical Engineering 201... ConferenceSeries Ltd is a reno

International Conference on Enzymology 2017

International Conference on Enzymology 2017... INTERNATIONAL CONFERENCE ON EN

20th MedExpo Tanzania 2017

20th MedExpo Tanzania 2017... The 19th MEDEXPO 2017 - Intern

5th International Conference and Exhibition on Pharmacology & Ethnopharmacology

5th International Conference and Exhibition o... Conference Series LLC invites

Cardiac Pharmacology 2017

Cardiac Pharmacology 2017... Conference Series LLC is a ren

  • Cannot retrive forecast data in module "mod_sp_weather".


Primary Eye Care (PEC) Centre inaugurated at Trilokpuri in E...
Max Healthcare's GroNoida, Uttar Pradesh, India, Friday, December
Hyderabad’s PharmaFidelity Growth Partners India, the India-foc
HUL December QuarterHindustan Unilever Limited (HUL) announced re
Narayana Hrudayalaya Bengaluru, Friday, January 18, 2013: With
Internet Based SolutNew Delhi, Delhi, India, Tuesday, April 23, 2

Press Release

New Delhi March 6, 2014:- India’s rising healthcare need...
Health Minister Dr HNew Delhi, June 11, 2014 - The Union Health M
Alcon Laboratories IAurigene Announced Significant Milestone in a
iocon gets DCGI nod New Delhi November 27, 2013: Biotechnology ma
Medical ConsultatioNew Delhi,February 5,2014: Medical Second Op
India-Based PharmaceCHAPEL HILL, N.C., Jan. 4, 2014  Across th


Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed tha...
Vice President InaugNew Delhi February 7, 2014: -The Vice Preside
An Initiative by HCGIndia - Emerging Leaders in Molecular Imaging
Health Ministers of New Delhi, September 11, 2013: The Health Min
Doctors, hospitals eNew Delhi January 2nd, 2014: Hospitals and me
New Assistance App fNew Delhi March 11,2014: The world’s leadin


Bangalore, Karnataka, India, Friday, December 21, 2012 -- ...
Global Recognition FAanjaneya Lifecare Selected in Pharmaceutical
Service Providers fr The HERO CYCLES INDIA HEALTH & WELL
Pharmaleaders Busine Global Hospitals Group, Infinite Computers,
Arogya World RecogniBangalore, Karnataka, India, Wednesday, Novem
ACG Worldwide ChairmIndian Education Society has bestowed this aw
Category: Company News

New Delhi, July 05, 2014 - Arecent McKinsey report states that Indian pharmaceutical market can reach USD 55 billion by 2020, and the market has also the potential to touch USD 70 billion, but it comes with a rider. To achieve this target, the industry should putconcerted efforts in the five key emerging opportunities namely, patented products, consumer healthcare drugs, biologics, vaccines, and the public health market.The same report also cautions that pricing control and economic slowdown may lead to a downturn in the market, to USD 35 billion.

While the external factors get difficult to control, the pharmaceutical companies need to strengthen the internal operational capabilities, in order to grow profitably. The rising industry complexity is a factor thatcompels the industry players to boost collaboration among the stakeholders and strive to sustain the performance. The major challenges that are impacting the business prospects for Indian pharmaceutical companies include quality of drugs, quality of clinical trials, and patent issues.Recently, some Indian pharmaceutical companies have been penalized in the USA for flouting FDA norms.

Cost leadership is a major differentiator for market competitiveness. Large pharmaceutical companies are normally adopting various strategic business initiatives such as ERP, Six Sigma, Lean, TQM, TPM, and contemporary management accounting techniques to optimize productivity and cost of the product. As business complexity in pharmaceutical sector is a given, it is an imperative for the pharmaceutical companies to adopt technology solutions to increase the operational excellence. With advanced technology solutions, the pharmaceutical companies can improve the visibility of data across the business processes and can take faster business decisions.

Inherent Challenges in Life Sciences Industry

Missing Operational Excellence

Pharmaceutical companies should strive foroperational excellence to thwart market competition. To achieve operational excellence, the pharmaceutical companies should focus on better quality, industry compliance, increased productivity, higher throughput, low utility cost, and less waste.However, the small and medium enterprises (SMEs) are reluctant to invest in technology. Lower technology investment restricts the operational efficiency of the company and increases the operational cost.

Lack of Data-driven Decisions

Since pharmaceutical industry is highly scientific process oriented, it is necessary for the companies to explore data-driven decision making. According to a Thompson Reuters report, 26.5% IT leaders catering to the IT needs of pharmaceutical industry predict that “big data” will play a major role in the decision making process.There is an urgent need to exploit“big data”to derive useful insights for better planning and decision-making. Unfortunately, the Indianpharmaceutical industry is slow to catch up with this technological trend.

Inefficient Supply Chain

Supply chain is the backbone of pharmaceutical industry. From drug discovery to clinical trials, to manufacturing, to distribution, each segment requires a robust supply chain management process to increase productivity and operational inefficiency. According to a report, an efficient supply chain management can reduce inventory holding by 25%-60% and improve the order fulfillment cycle time by 30%-50%. But the inability of developing an efficient supply chain costs the companies heavily. For example, poor inventory planning can cost a pharmaceutical company 10%-18% of net revenues.

Stringent Regulatory Control

There is an increasing need for compliance with regulatory norms of different countries and international agencies such as FDAand WHO. If a company wishes to market the products in the US region, an approval from FDA is mandatory. The clinical trial process also attracts major attention from the FDA regarding safety, efficacy, capacity, and purity of the drug. The pharmaceutical companies are also subject to various state and federal laws regarding production environment, safety, and environment protection.

Poor Drug Quality

Quality is a major issue with pharmaceutical manufacturers. In 2013, a major Indian pharmaceutical company was penalized in the US for flouting the FDA quality norms.There are many instances when Indian regulators collude with local manufacturers to approve the products. This allows smaller companies to manufacture sub-standard drugs and market it in the developing countries.The sub-standard drugs available at lower price pose a threat to the quality drugs marketed by leading pharmaceutical companies.

Leveraging the Technology to Optimize Growth Opportunities

What’s required for Indian life sciences companies today to mitigate the daunting challenges is, to adopt technology solutions. For example, Tectura® Life Sciences solution, built on Microsoft Dynamics, covers all business areas: from purchasing, sales, production, financial accounting, quality control, vendor rating, raw material data management, laboratory systems, resource management, warehouse management, and logistics, to marketing and distribution. Many leading life sciences companies of India have leveraged this solution to improve their operational efficiency.Life sciences companies require customized solution to address their challenges.For example, order management, formulation,active ingredients administration, inventory management, lot tracing, sequence planning, quality management, supply chain management, and production planning are the key areas to be integrated.

Bringing in Manufacturing Excellence

Companies need a solution having greater flexibility, easy integration, and extensive features to support the business operations. Components like manufacturing specification provide data to core ERP solution through an interface, which is version controlled and user authenticated. Similarly, formulae,BOMs, and recipes are critical data structures that life sciences companies adhere to strictly. Tectura Life Sciences offers extensive functionalities to configure manufacturing specifications, recipes, formula’s bills of materials (BOMs), and work plans. The manufacturing specifications can be integrated with Microsoft Dynamics solution. It helps compiling all necessary work instructions basis the production plan. Being version controlled and protected by password, this module ensures that data security is maintained.

Conforming to Regulatory Compliances

As life sciences companies need to meet the FDA/GMP/WHO compliances, there is an urgent requirement for the companies to look for a comprehensive solution that can help reduce the risk of non-compliance along with complete visibility into the quality of products. Tectura Life Sciences solution allows companies to ensure adhering to FDA regulations, complying with standard operating procedures, and validating the industry checklists.This solution is compliant with GMP requirements, and maintains audit trails and signature records for both manual and automated transactions to satisfy 21 CFR Part 11.

Ensuring Better Quality of Products

In life sciences industry, quality management acts as an ethical guide to deliver the product as promised to customers. The industry has a mandate to comply with a number of regulatory compliances, which again largely address to the quality of the product. Tectura Quality Management solution offers a wide range of measures such as test plans, process tests, test orders, test accuracy control, skip-lot function, and vendor rating to thwart the challenges. The solution also provides components to integrate client-defined measures to abide by the quality policies of the company. Companies can easily integrate all test areas with procedural documents to ensure easy validation.

Faster Product Recall

Lot tracing is a critical component for life sciences operational process. For instance, during FDA audits if any product fails to meet the standards, then the company should recall the product immediately. Tectura's Life Sciences solution enables complete lot and serial traceability with forward and backward tracking capability across the production chain. This feature improves the response time for product recall and ensures peace of mind for the manufacturers.

Efficient Production Planning

During production planning and control stage, life sciences companies need planning functionalities that allow optimal resource utilization. Companies require integrated sequence planning to configure planning parameters, schedules, resource availability, and sequencing. Mostly, at production floor short-term changes are expected due to machine failures and unplanned customer orders. The production manager should ensure that resource utilization is optimized and transparency is built into the system. With advance sequence planning module of Tectura Life Sciences, companies can even handle ad hoc requirements more efficiently without disturbing the scheduled jobs. During scheduling and sequence optimization, the production floor manager can verify inventory to check whether the required materials are available in the stock and right measures are predefined in the system.

Managing Cost Optimally

As life sciences companies use myriads of raw materials to compose a complex molecule, calculating the costing of individual ingredients is necessary. While many ERP solutions have inherent issues in calculating the cost of a product, Tectura Life Sciences solution helps calculate the production cost basis the raw material price and the amount of portion used. Various fixed and variable costs are defined to estimate the final cost of the finished product. Using this solution, companies can define the size of lots and relationship between quantity and unit cost.


As the Indian life sciences industry is faces global competition, itiscrucial for the business owners and decision makers of the company to rely on comprehensive business solutions to mitigate the daunting challenges. Many leading pharmaceutical companies have trusted innovative business solutions like Tectura Life Sciencessolution that integrates all business processes, including production and planning, quality, supply chain, sales and marketing, and finance and accounting. It allows companies to bring in operational excellence,conform to quality and regulatory compliance,and increase profitability.

About the Author

Mr. Chetan Pathak, Corporate Operations Director, Tectura India

Managing at the helm of Tectura India, Chetan exemplifies Tectura’s commitment to delivering exceptional and sustained value to the clients. Chetan joined Tectura India as Corporate Operations Director in April 2009. With an extensive and diverse experience of over 26 years in the areas of technology and consulting business, Chetan spearheads Tectura’s strategy for operations in India, Nepal, Bangladesh, Sri Lanka, Maldives, Mauritius, and New Caledonia. Chetan is Tectura India’s primary decision- and policy-maker, setting the tone for company’s values, ethics, and culture.

In this capacity, Chetan provides complete leadership on strategic and operational issues. A proven leader with deep expertise in executing on strategic global, regional, and local initiatives and goals, Chetan manages growth of Tectura India’s business, profitability, and customer satisfaction. With a passion for mentoring and coaching, Chetan builds up the path for enterprise leadership team. At Tectura India, he drives three revenue streams – Local Business, Direct Offshoring, and Inter-company Business. Chetan leads relationship management with Microsoft and various channel partners. His focus for business excellence has helped Tectura India achieve many awards from Microsoft locally and globally.

Prior to joining Tectura India, Chetan was the Vice President – India Operations, Ramco Systems. At Ramco Systems, he was responsible for managing the Enterprise Solutions business, Enterprise Process Solutions business, SaaS business, and BPO. Before joining Ramco Systems, Chetan also worked with leading technology organizations such as Tata Unisys and IDM Ltd. Chetan holds a BE degree in Mechanical Engineering and MBA in Marketing Management from Gujrat University. CCI Newswire

Email address:


The Hotel Times

 The Hotel Times We are, The Hotel Times an online hospitality news portal to provide quality info

Read more


Exclusive on Pharma Times

New Delhi, June 26, 2014 - The days

New Delhi February 25, 2014:- Disti

MUMBAI, MAR 28, 2014 : Lupin Ltd

Daily Updates -International

Daily Updates - National

  • 1
  • 2
Prev Next
Omron Blood Pressure Monitor, HEM-7113
Automatic Capsule Filling Machine (PF-150)
Gelusil liquid antacid - Pfizer’s
The Varilux 3.0 range lenses - Essilor
Blossom Kochhar Aroma Magic Anti Pigmentation Serum
 The Property Times